Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00860743 · ClinicalTrials.gov registry record · Early Phase 1

Respiratory and Autonomic Plasticity Following Intermittent Hypoxia

A Early Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Early Phase 1
Development phase
63
Enrollment target

NCT00860743: Completed Early Phase 1 study, sponsored by VA Office of Research and Development.

NCT00860743 is a Early Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00860743, a Early Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Early Phase 1
Development phase
63 participants
Enrollment target

Study Summary

The prevalence of obstructive sleep apnea is high in the Veteran population. If not treated promptly, sleep apnea may result in daytime fatigue which may lead to increased prevalence of accidents while driving or in the workplace. Recent large scale epidemiological studies have shown that the prevalence of excessive daytime sleepiness increases in individuals who suffer from obstructive sleep apnea. Obstructive sleep apnea may also result in the development of hypertension and other cardiovascular disorders. Previous findings have shown that subjects with sleep apnea have a greater risk for developing coronary vascular disease compared to individuals that do not suffer from sleep apnea Thus, a significant amount of evidence suggests that sleep apnea is a major health concern in the Veteran population. Consequently, determining the mechanisms that may impact on the severity of sleep apnea and increase the prevalence of cardiovascular incidents associated with this disorder is important, as is discovering novel treatments.

Interventions

  • DRUG Antioxidant cocktail

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2009-09
Est. Completion 2013-09
Phase Early Phase 1

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00860743

The ClinicalTrials.gov registry entry for NCT00860743 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Antioxidant cocktail is the first listed.

NCT00860743 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00860743 about?

NCT00860743 is a clinical study titled "Respiratory and Autonomic Plasticity Following Intermittent Hypoxia". The prevalence of obstructive sleep apnea is high in the Veteran population. If not treated promptly, sleep apnea may result in daytime fatigue which may lead to increased prevalence of accidents while driving or in the workplace. Recent large scale epidemiological studies have shown that the preval...

What is the current status of trial NCT00860743?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 63 participants. The study started on 2009-09. Estimated completion is 2013-09.

What interventions are being tested in trial NCT00860743?

The interventions under investigation include: Antioxidant cocktail (DRUG).

Who is sponsoring clinical trial NCT00860743?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.